Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19655342 | 0.84 | KDM4E (0.43) | KDM4EATML3MBTL1ALDH1A1MAPT | |
| SCHEMBL19655334 | 0.82 | L3MBTL1 (0.47) | KDM4EATML3MBTL1ALDH1A1MAPT | |
| SCHEMBL22186227 | 0.81 | KDM4E (0.44) | KDM4EATML3MBTL1ALDH1A1MAPT | |
| SCHEMBL24221100 | 0.81 | KDM4E (0.34) | KDM4EATML3MBTL1ALDH1A1MAPT | |
| SCHEMBL24030253 | 0.81 | KDM4E (0.31) | KDM4EALDH1A1MAPTHPGD | |
| SCHEMBL20968675 | 0.81 | KDM4E (0.39) | KDM4EATML3MBTL1ALDH1A1MAPT | |
| SCHEMBL19653784 | 0.80 | KDM4E (0.40) | KDM4EATML3MBTL1ALDH1A1MAPT | |
| SCHEMBL19655336 | 0.80 | L3MBTL1 (0.45) | KDM4EATML3MBTL1ALDH1A1MAPT | |
| SCHEMBL20348042 | 0.79 | L3MBTL1 (0.40) | KDM4EATML3MBTL1ALDH1A1MAPT | |
| SCHEMBL22425405 | 0.79 | KDM4E (0.33) | KDM4EATML3MBTL1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020085793-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME | 덕산네오룩스 주식회사 | 2020-04-30 | — | — | WO | disclosed |